Mammographic density and molecular subtypes of breast cancer

British Journal of Cancer

Volumn 107, Issue 1, 2012, Pages 18-23

  Eriksson, L ^a   Hall, P ^a   Czene, K ^a   Dos Santos Silva, I ^b   McCormack, V ^b,c   Bergh, J ^a,d   Bjohle, J ^a   Ploner, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Breast cancer; mammographic density; molecular subtypes

Indexed keywords

ADULT; AGED; ANALOG DIGITAL CONVERTER; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; COMPUTER PROGRAM; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; PRIORITY JOURNAL; RADIATION MEASUREMENT; RISK ASSESSMENT; RISK FACTOR; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; RISK FACTORS;

EID: 84862996537     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.234     Document Type: Article

References (37)

1. Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M (2010) Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 17(Suppl 3): 211-218
2. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3): 227-236 (Pubitemid 46143226)
3. Boyd NF, Martin LJ, Yaffe M, Minkin S (2009) Mammographic density. Breast Cancer Res 11(Suppl 3): S4
4. Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2011a) Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 13(6): 223
5. Boyd NF, Melnichouk O, Martin LJ, Hislop G, Chiarelli AM, Yaffe MJ, Minkin S (2011b) Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol 29(22): 2985-2992
6. Brekelmans CT, Peeters PH, Faber JA, Deurenberg JJ, Collette HJ (1994) The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 30(3): 223-232 (Pubitemid 24262117)
7. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1996a) Automated analysis of mammographic densities. Phys Med Biol 41(5): 909-923 (Pubitemid 26156945)
8. Byng JW, Boyd NF, Little L, Lockwood G, Fishell E, Jong RA, Yaffe MJ (1996b) Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev 5(5): 319-327 (Pubitemid 27006989)
9. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60(14): 3744-3748 (Pubitemid 32204562)
10. Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, Liu ET, Miller L, Ploner A, Smeds J, Bergh J, Pawitan Y (2006) Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 8(4): R34
11. Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH (2010) Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19(5): 1219-1228
12. Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, Thoresen SO, Foulkes WD, Akslen LA (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 14(5): 1108-1112 (Pubitemid 40656455)
13. Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N (2009) Triple-negative breast cancer-current status and future directions. Ann Oncol 20(12): 1913-1927
14. Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH (2005) Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev 14(11 Part 1): 2634-2640 (Pubitemid 41752726)
15. Heusinger K, Jud SM, Haberle L, Hack C, Adamietz BR, Meier-Meitinger M, Lux MP, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA (2012) Association of mammographic density with hormone receptors in invasive breast cancers-results from a case-only study. Int J Cancer; e-pub ahead of print 6 March 2012; doi:10.1002/ijc.27515
16. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, Wong JE, Liu ET, Bergh J, Kuznetsov VA, Miller LD (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66(21): 10292-10301 (Pubitemid 44799747)
17. Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet 355(9200): 270-274 (Pubitemid 30068519)
18. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V (1996) Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276(1): 33-38 (Pubitemid 26231053)
19. Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH (2011) Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res 13(5): R103
20. Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G (2009) Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 18(2): 479-485
21. Maskarinec G, Nagata C, Shimizu H, Kashiki Y (2002) Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer 102(1): 29-33
22. McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6): 1159-1169
23. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102(38): 13550-13555 (Pubitemid 41420886)
24. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, Shaw PM, Smeds J, Skoog L, Wedren S, Bergh J (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7(6): R953-R964
25. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797): 747-752
26. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara E S, Li CI (2012) Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 22(5): 340-348
27. R Development Core Team (2008) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria. ISBN 3-900051-07-0, URL: http://www.R-project.org
28. Sorlie T (2007) Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol 360: 91-114
29. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19): 10869-10874 (Pubitemid 32878711)
30. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14): 8418-8423 (Pubitemid 36842560)
31. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100(18): 10393-10398 (Pubitemid 37071889)
32. StataCorp (2009) Stata Statistical Software: Release 11. StataCorP LP: College Station, TX
33. Stone J, Ding J, Warren RM, Duffy SW, Hopper JL (2010) Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 12(6): R97
34. Stone J, Warren RM, Pinney E, Warwick J, Cuzick J (2009) Determinants of percentage and area measures of mammographic density. Am J Epidemiol 170(12): 1571-1578
35. Thijssen JH (2004) Local biosynthesis and metabolism of oestrogens in the human breast. Maturitas 49(1): 25-33 (Pubitemid 39209368)
36. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9(6): 217
37. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumour characteristics. J Natl Cancer Inst 103(15): 1179-1189